Weekly Roundup: Apple, Eli Lilly, Trade Desk
On this episode of Stock Movers:- Apple (AAPL) accounted for about a third of of the S&P 500’s weekly gain after announcing a further massive investment in US manufacturing, which should mitigate tariff costs over the longer term. - Eli Lilly (LLY) had its worst week since 2008 after investors reacted to disappointing data on weight loss pill. The new weight-loss pill had lower weight loss and higher rates of nausea and vomiting than anticipated in a study, according to the company. BMO analyst Evan Seigerman said of Lilly's pill, "What this shows to me is that it's still a good drug…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.